← back to search

Ami A. Shah

Johns Hopkins University · US
🔎 Find collaborators in Pathology and Forensic Medicine · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pathology and Forensic Medicine · Pulmonary and Respiratory Medicine
Research interest
Research interests include Systemic Sclerosis and Related Diseases, Inflammatory Myopathies and Dermatomyositis, Pulmonary Hypertension Research and Treatments, and Cancer Immunotherapy and Biomarkers.
h-index
53
citations
9,087
works
290
NIH funding
primary concept
email

Recent publications

Xist ribonucleoproteins promote female sex-biased autoimmunity
Cell 2024cited by 195position: middledoi
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
Annals of the Rheumatic Diseases 2023cited by 71position: middledoi
Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension
American Journal of Physiology-Lung Cellular and Molecular Physiology 2023cited by 27position: middledoi
Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis
ACR Open Rheumatology 2023cited by 0position: middledoi
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation
Clinical and Experimental Rheumatology 2022cited by 2position: middledoi
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort
Arthritis Research & Therapy 2021cited by 67position: middledoi
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc
Best Practice & Research Clinical Rheumatology 2021cited by 43position: middledoi
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi‐center US‐based longitudinal registry
International Journal of Rheumatic Diseases 2021cited by 10position: middledoi
Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic Sclerosis
Arthritis & Rheumatology 2020cited by 73position: middledoi
Predictive Significance of Serum Interferon‐Inducible Protein Score for Response to Treatment in Systemic Sclerosis–Related Interstitial Lung Disease
Arthritis & Rheumatology 2020cited by 40position: middledoi
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
Annals of the Rheumatic Diseases 2019cited by 225position: middledoi
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
Annals of the Rheumatic Diseases 2019cited by 174position: middledoi
<i>HLA</i>and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry
Proceedings of the National Academy of Sciences 2019cited by 74position: middledoi
Epigenetic activation and memory at a <i>TGFB2</i> enhancer in systemic sclerosis
Science Translational Medicine 2019cited by 64position: middledoi
Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen
Seminars in Arthritis and Rheumatism 2018cited by 157position: lastdoi
Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis–Associated Versus Idiopathic Pulmonary Arterial Hypertension
Circulation 2018cited by 142position: middledoi
Brief Report: Whole‐Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans
Arthritis & Rheumatology 2018cited by 15position: middledoi
The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma‐Associated Raynaud's Phenomenon: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
Arthritis & Rheumatology 2017cited by 118position: middledoi
Clinical and serological features of systemic sclerosis in a multicenter African American cohort
Medicine 2017cited by 113position: middledoi
Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma
Arthritis & Rheumatology 2017cited by 76position: firstdoi
Rheumatic and Musculoskeletal Immune‐Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature
Arthritis Care & Research 2016cited by 394position: lastdoi
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
Annals of the Rheumatic Diseases 2016cited by 391position: middledoi
Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension
Circulation 2016cited by 210position: middledoi
Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology
Rheumatic Disease Clinics of North America 2016cited by 118position: middledoi
Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer
Proceedings of the National Academy of Sciences 2016cited by 106position: middledoi
The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil
The Journal of Rheumatology 2016cited by 24position: firstdoi
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients
Arthritis Research & Therapy 2016cited by 22position: middledoi
Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome
Arthritis & Rheumatology 2015cited by 146position: middledoi
Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer‐Associated Scleroderma
Arthritis & Rheumatology 2015cited by 120position: firstdoi
Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)
Current Respiratory Medicine Reviews 2015cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Laura K. Hummers · Johns Hopkins University10 papers (2012–2022)Fredrick M. Wigley · Johns Hopkins University10 papers (2012–2019)Virginia Steen · Georgetown University8 papers (2013–2023)Dinesh Khanna · University of Michigan8 papers (2012–2023)Shervin Assassi · University of Houston7 papers (2012–2022)Tracy Frech · Vanderbilt University7 papers (2013–2022)Clifton O. Bingham · Johns Hopkins University7 papers (2015–2023)Laura C. Cappelli · Apple (Israel)6 papers (2016–2023)Jessica Gordon · Hospital for Special Surgery6 papers (2013–2022)Flavia V. Castelino · Georgetown University6 papers (2015–2022)Victoria K. Shanmugam · Georgetown University6 papers (2013–2022)Faye N. Hant · Georgetown University6 papers (2013–2022)Livia Casciola‐Rosen · Johns Hopkins University5 papers (2013–2017)Antony Rosen · Stanford University5 papers (2013–2017)Elana J. Bernstein · Columbia University Irving Medical Center5 papers (2020–2022)Robyn T. Domsic · University of Pittsburgh5 papers (2013–2023)Monique Hinchcliff · Yale University4 papers (2013–2021)Dung T. Le · Johns Hopkins University3 papers (2016–2019)Evan J. Lipson · Smilow Cancer Hospital3 papers (2016–2019)Paul M. Hassoun · Johns Hopkins Bayview Medical Center3 papers (2013–2018)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pathology and Forensic Medicine · Pulmonary and Respiratory Medicine →